Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
What is ‘Auld Lang Syne’? Why we sing this song at midnight on New Year’s Eve.31.12.2025 - 2US healthcare spending soars to over $5 trillion in 202414.01.2026
- 3Monetary Wellness: Planning Tips for Independence from the rat race01.01.1
- 4Greenland’s melting ice and landslide-prone fjords make the oil and minerals Trump is eyeing dangerous to extract06.01.2026
- 5James Webb Space Telescope watches 'Jekyll and Hyde' galaxy shapeshift into a cosmic monster19.12.2025
- Trial of pro-Palestine activist begins
- Here's how 'Bridgerton' fans can watch the first episode of Season 4 before its Netflix release later this month
- Is Chinese food truly flavorful?
- Figure out How to Introduce Sunlight powered chargers on Your Rooftop securely
- Elite Execution Wall televisions for Film Darlings
- Ergonomic Office Seats for Work spaces
- ByHeart infant formula recall tied to botulism outbreak puts parents on edge
- New movies to watch this weekend: See 'We Bury the Dead' in theaters, rent 'Wicked: For Good,' stream 'The Unbreakable Boy' on Starz
- The Most Encouraging New companies to Look Out For
